Veradermics MANE
NYSE MANE
$127.10 +4.82 (+3.94%)
As of: Oct 20, 2026 · 3:59 PM EDT

Veradermics (MANE) Common Equity (2024 - 2026)

Updated

Veradermics (MANE) recorded Common Equity of $813.61 million in Q2 2026, compared with -$76.07 million a year earlier and up 108.3% from the prior quarter.

Analysis

Veradermics (MANE) Common Equity (2024 - 2026) Analysis & Trends

At the end of FY2025, Veradermics reported Common Equity of -$121.01 million.

  • Across earlier years, Common Equity came in at -$48.48 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 33.88 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 84.97 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -5.94 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 41.98 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 41.95 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 50.37 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 11.69 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 11.83 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 85.49 Bn
10 Veradermics 5.17 Bn 3.77 Bn - 813.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 813.61 Mn
Mar 31, 2026 390.64 Mn
Dec 31, 2025 -121.01 Mn
Jun 30, 2025 -76.07 Mn
Mar 31, 2025 -60.67 Mn
Dec 31, 2024 -48.48 Mn
API Access

Veradermics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=MANE&period=max&api_key=YOUR_API_KEY